HMC
Harvard Management Company Portfolio holdings
AUM
$1.44B
This Quarter Return
+3.46%
1 Year Return
+33.17%
3 Year Return
+230.83%
5 Year Return
+163.57%
10 Year Return
+194.2%
AUM
$1.71B
AUM Growth
+$1.71B
(-1.8%)
Cap. Flow
+$14M
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
83.44%
Holding
47
New
9
Increased
3
Reduced
4
Closed
7
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$163M |
| 2 |
Meta Platforms (Facebook)
META
|
$65.7M |
| 3 |
Affirm
AFRM
|
$32.9M |
| 4 |
Rocket Lab Corporation Common Stock
RKLB
|
$16.1M |
| 5 |
Sana Biotechnology
SANA
|
$15.6M |
Top Sells
| 1 |
Palo Alto Networks
PANW
|
$91.3M |
| 2 |
Intercontinental Exchange
ICE
|
$81.7M |
| 3 |
Apple
AAPL
|
$78M |
| 4 |
DaVita
DVA
|
$49.2M |
| 5 |
Unity
U
|
$20.5M |
Sector Composition
| 1 | Healthcare | 34.02% |
| 2 | Communication Services | 23.75% |
| 3 | Technology | 20.88% |
| 4 | Consumer Discretionary | 13.04% |
| 5 | Industrials | 1.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$3.45T
| $267M | 15.62% | 1,883,445 -551,458 | -23% | -$78M |
|
2
Royalty Pharma
RPRX
$15.6B
| $258M | 15.13% | 7,142,856 | – | – |
|
|
3
Meta Platforms (Facebook)
META
$1.86T
| $242M | 14.18% | 713,073 +193,617 | +37% | +$65.7M |
|
4
Light & Wonder
LNW
$7.76B
| $223M | 13.04% | 2,678,571 | – | – |
|
|
5
Alphabet (Google) Class A
GOOGL
$2.57T
| $163M | 9.57% | +61,070 | New | +$163M |
|
|
6
Affirm
AFRM
$28.8B
| $89.8M | 5.26% | 753,804 +276,383 | +58% | +$32.9M |
|
7
AbCellera Biologics
ABCL
$1.25B
| $82.3M | 4.82% | 4,105,095 | – | – |
|
8
Invesco QQQ Trust
QQQ
$364B
| $36.3M | 2.13% | 101,448 -774 | -0.8% | -$277K |
|
9
Recursion Pharmaceuticals
RXRX
$2.04B
| $34.7M | 2.04% | 1,509,254 | – | – |
|
10
iShares Core S&P 500 ETF
IVV
$662B
| $28.2M | 1.65% | 65,342 | – | – |
|
11
10x Genomics
TXG
$1.74B
| $27.1M | 1.59% | 186,143 | – | – |
|
|
12
Sana Biotechnology
SANA
$777M
| $26.2M | 1.54% | 1,163,601 +694,852 | +148% | +$15.6M |
|
13
Revolution Medicines
RVMD
$7.1B
| $18.4M | 1.08% | 670,382 | – | – |
|
14
Relay Therapeutics
RLAY
$619M
| $17.1M | 1% | 541,124 | – | – |
|
|
15
Rocket Lab Corporation Common Stock
RKLB
$23.4B
| $16.1M | 0.95% | +1,000,000 | New | +$16.1M |
|
16
SPDR Gold Trust
GLD
$107B
| $15.1M | 0.89% | 91,955 | – | – |
|
17
Praxis Precision Medicines
PRAX
$958M
| $14.4M | 0.84% | 778,517 | – | – |
|
18
PureCycle Technologies
PCT
$2.57B
| $14.2M | 0.83% | 1,069,600 | – | – |
|
19
Tenaya Therapeutics
TNYA
$184M
| $13.9M | 0.81% | +673,270 | New | +$13.9M |
|
20
Generation Bio
GBIO
$40.4M
| $12.8M | 0.75% | 510,354 -1,995 | -0.4% | -$50K |
|
21
Fulcrum Therapeutics
FULC
$351M
| $11.6M | 0.68% | 410,714 | – | – |
|
|
KNTE
22
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $11.5M | 0.67% | 498,001 | – | – |
|
|
MEKA
23
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
| $11.1M | 0.65% | +1,000,000 | New | +$11.1M |
|
24
Pliant Therapeutics
PLRX
$101M
| $9.49M | 0.56% | 562,379 | – | – |
|
25
Nurix Therapeutics
NRIX
$714M
| $9.43M | 0.55% | 314,762 | – | – |
|